| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.040.796 | 2.305.383 | 3.165.399 | 4.001.827 | 4.882.752 | 6.066.415 | 5.492.366 | 6.263.252 | 8.608.911 | 9.125.937 |
| Total Income - EUR | 2.480.439 | 2.432.601 | 3.325.768 | 4.244.012 | 5.670.679 | 7.111.015 | 6.299.752 | 6.783.386 | 8.589.689 | 9.389.897 |
| Total Expenses - EUR | 2.085.254 | 2.158.818 | 2.776.325 | 3.915.699 | 5.163.734 | 5.702.990 | 5.569.477 | 6.449.508 | 7.912.743 | 8.232.158 |
| Gross Profit/Loss - EUR | 395.185 | 273.784 | 549.444 | 328.313 | 506.944 | 1.408.025 | 730.275 | 333.878 | 676.946 | 1.157.739 |
| Net Profit/Loss - EUR | 340.122 | 227.815 | 442.221 | 276.181 | 427.221 | 1.199.489 | 636.195 | 280.310 | 573.110 | 1.011.650 |
| Employees | 49 | 58 | 87 | 107 | 130 | 141 | 134 | 136 | 145 | 151 |
Check the financial reports for the company - Stratec Biomedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 699.167 | 3.266.136 | 3.392.405 | 3.054.544 | 2.894.663 | 2.717.460 | 2.615.397 | 2.594.311 | 5.066.042 | 4.664.142 |
| Current Assets | 1.201.588 | 765.759 | 1.130.292 | 1.687.670 | 2.138.773 | 3.269.407 | 3.579.825 | 4.065.468 | 1.912.711 | 2.726.824 |
| Inventories | 46.074 | 107.813 | 196.740 | 381.233 | 1.064.241 | 1.910.241 | 2.567.516 | 3.095.655 | 178.847 | 151.100 |
| Receivables | 254.389 | 105.564 | 358.971 | 140.115 | 501.405 | 509.013 | 225.972 | 869.206 | 659.439 | 925.442 |
| Cash | 901.125 | 552.382 | 574.582 | 1.166.322 | 573.127 | 850.154 | 786.336 | 100.608 | 1.074.425 | 1.650.282 |
| Shareholders Funds | 736.099 | 956.407 | 1.382.444 | 1.633.254 | 2.028.845 | 3.189.872 | 3.755.328 | 4.047.289 | 4.608.126 | 5.594.023 |
| Social Capital | 49.100 | 48.599 | 47.777 | 46.900 | 45.992 | 45.120 | 44.119 | 44.256 | 44.122 | 43.876 |
| Debts | 1.176.754 | 3.084.033 | 3.157.093 | 3.345.405 | 3.231.223 | 3.013.132 | 2.649.656 | 2.703.669 | 2.399.745 | 1.981.830 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Stratec Biomedical Srl